Echocardiography-guided aortic cannulation by the Seldinger technique for type A dissection with cerebral malperfusion

Shimura, Shinichiro; Odagiri, S; Furuya, Hidekazu; Okada, Kazutaka; Ozawa, Keisuke; Nagase, Haruhiro; Yamaguchi, M.; Cho, Yasunori

doi:10.1016/j.jtcvs.2019.02.097

Cited by 29 publications

(20 citation statements)

References 35 publications

(55 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is fast and safe, particularly when a combination of epiaortic and transesophageal echocardiography is used to ensure truelumen cannulation. 1,6 Near-infrared spectroscopic data from this study lend further support to the efficacy of central cannulation. Significant increases in regional cerebral oxygen saturation levels were seen in both the right (from 55% to 74%) and left (from 66% to 79%) hemispheres on the initiation of cardiopulmonary bypass.…”

Section: Leonard N Girardi MDsupporting

confidence: 61%

See 1 more Smart Citation

Commentary: Central aortic cannulation for acute type A dissection—Not just for patients with cerebral malperfusion

Girardi

2020

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Leonard N Girardi MDsupporting

confidence: 61%

“…Five such patients were not offered surgery in the report of Shimura and colleageus. 1 Devastating is illdefined, however, and left to the discretion of the consulting surgeon. Postoperative complications are also not benign.…”

Section: Leonard N Girardi MDmentioning

confidence: 99%

Commentary: Central aortic cannulation for acute type A dissection—Not just for patients with cerebral malperfusion

Girardi

2020

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

“…TACE procedure and treatment response evaluation. All patients were treated with TACE using the Seldinger technique (15). Ultrasound-guided percutaneous insertion of a retrograde catheter was performed from the femoral artery through the celiac trunk and hepatic artery, and the final location of the catheter was determined by the tumor location.…”

Section: Methodsmentioning

confidence: 99%

Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma

et al. 2021

View full text Add to dashboard Cite

The present study aimed to investigate the effects of transarterial chemoembolization (TACE) on the immune function of patients with hepatocellular carcinoma (HCC). A total of 114 patients with HCC were selected and their peripheral blood was collected before and 1 month after TACE treatment. Flow cytometry and reverse transcription-quantitative PCR were performed to analyze the changes in immune function in patients before and after treatment. Kaplan-Meier curves were plotted for survival analysis. The programmed cell death ligand 1 (PD-L1) and programmed cell death protein 1 (PD1) expression before TACE treatment were significantly higher in patients with poor TACE response compared with those patients with well response. Higher PD-L1 mRNA expression in the peripheral blood mononuclear cells after TACE predicted a superior prognosis. After TACE treatment, the proportion of CD4 + /CD8 + cells were decreased while the expression levels of programmed cell death protein 1 (PD1) were significantly increased. To conclude, TACE could reduce the proportion of CD4 + /CD8 + cells and improve the mRNA expression levels of PD1 in patients with HCC. The expression levels of PD1 and PD-L1 were closely related to the therapeutic effect of TACE and the prognosis of patients with HCC. TACE combined with immunotherapy may have potential clinical value for patients with HCC.

show abstract

“…All cases were performed through a median sternotomy. Since 2014, we preferentially performed central cannulation of the true lumen with epi‐aortic ultrasonography guidance and Seldinger technique 17,18 . Trans‐esophageal echocardiography confirmed true lumen perfusion.…”

Section: Methodsmentioning

confidence: 99%

Management of malperfusion: New York approach and outcomes

2020

View full text Add to dashboard Cite

Background and Aim Aortic branch malperfusion complicates up to one‐third of acute type A aortic dissection (ATAAD), and it is a strong predictor of poor outcomes. We analyzed our results for the surgical management of this high‐risk cohort. Methods We queried our aortic database for consecutive patients undergoing ATAAD repair. Those presenting with malperfusion were compared with those without. Outcomes were compared using univariate and multivariate analysis. Results From 1997 to 2019, a total of 336 patients underwent ATAAD repair. A total of 97 ATAAD patients presented with malperfusion. Malperfusion patients were more likely to be male (54.8% vs. 75.3%; p = .001), have had a prior myocardial infarction (11.9% vs. 26.8%; p = .001), to present with preoperative renal dysfunction (22.2% vs. 54.6%; p < .001), and to present with shock (12.6% vs. 28.9%; p = .001). The malperfusion group more often underwent coronary artery bypass grafting (5.4% vs. 24.7%; p < .001), and required additional noncardiac procedures 10.3% of the time. Operative mortality (0.8% vs. 15.5%; p < .001) and major adverse events (MAEs) (7.6% vs. 20.6%; p = .001) were both greater for the malperfusion patients. Ejection fraction, diabetes, and malperfusion were predictors of MAEs. Cerebral, coronary, mesenteric, and multiple vascular bed malperfusion were predictors of MAEs, while extremity, renal, and spinal were not. Conclusion Improving outcomes for this high‐risk cohort requires rapid diagnosis and reversal of ischemia while minimizing the risk of aortic rupture, irrespective of the strategic approach.

show abstract

Echocardiography-guided aortic cannulation by the Seldinger technique for type A dissection with cerebral malperfusion

Cited by 29 publications

References 35 publications

Commentary: Central aortic cannulation for acute type A dissection—Not just for patients with cerebral malperfusion

Commentary: Central aortic cannulation for acute type A dissection—Not just for patients with cerebral malperfusion

Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma

Management of malperfusion: New York approach and outcomes

Contact Info

Product

Resources

About